Last reviewed · How we verify
NCT06800170: HP-phD_Adolesc
Treatment of Menstrual Cycle Alterations in Adolescents
NA trial testing myo-Inositol plus DIoscorea Villosa in Amenorrhea in 20 participants. Currently enrolling.
1 June 2026
Quick facts
| Lead sponsor | Lo.Li.Pharma s.r.l |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 1 June 2025 |
| Primary completion | 1 June 2026 |
| Estimated completion | 1 December 2026 |
| Sites | 3 locations across Georgia, Italy, Russia |
Drugs / interventions tested
- myo-Inositol plus DIoscorea Villosa
Conditions studied
- Amenorrhea — all drugs for Amenorrhea →
- Oligomenorrhea — all drugs for Oligomenorrhea →
- PCOS (Polycystic Ovary Syndrome) — all drugs for PCOS (Polycystic Ovary Syndrome) →
Sponsor
Lo.Li.Pharma s.r.l
Who can join
Adults 14 to 19, female only, with Amenorrhea or Oligomenorrhea. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Menstrual cycle regularity
Time frame: 6 months
The intervention is targed to adolescent patients suffering from menstrual cycle alterations. Particularly, we aim to asses the regularization of the menstrual cycle in those patients with polimenhorrea and oligo-/ amenorrhea, with irregular menstrual cycle (shorter than 21 days or longer than 35 days). The purpose of the study is to compare the percentage of patients exhibiting a regular menstru
Sponsor's own description
the aim of the present study is intended to evaluate how treatment with Myo-Inositol and Dioscorea Villosa can help improve menstrual cycle irregularities in adolescents, both with and without PCOS.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06800170
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Amenorrhea
Currently open trials in the same condition.
- NCT06280807 — Observation of Environment and Reproductive-Endocrine Effects · recruiting
- NCT04424576 — Ovarian Morphology in Girls · recruiting
- NCT03916978 — Autologous PRP Intra Ovarian Infusion to Restore Ovarian Function in Menopausal Women · Phase 2, PHASE3 · recruiting
- NCT01500447 — Inherited Reproductive Disorders · recruiting
Other Lo.Li.Pharma s.r.l trials
Trials by the same sponsor.
- NCT07257770 — Local Treatment of Breast Pain Based on the Daily Use of a Topical Gel · NA · recruiting
- NCT06715527 — Treatment of Women With Hyperandrogenic PCOS With Two Different Ratios of Myo-inositol:D-chiro-inositol: A Comparison · NA · completed
- NCT06639698 — Treatment of Women With PCOS of Phenotype D · NA · completed
- NCT05674318 — The Effect of Alpha-lactalbumin on Microbiota Composition · NA · completed
- NCT05678114 — Inositol Treatment in Different Type of PCOS Phenotype · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06800170 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Lo.Li.Pharma s.r.l
- Last refreshed: 5 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06800170.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing